BR0317876A - Composições de liberação de droga tópica estáveis - Google Patents

Composições de liberação de droga tópica estáveis

Info

Publication number
BR0317876A
BR0317876A BR0317876-5A BR0317876A BR0317876A BR 0317876 A BR0317876 A BR 0317876A BR 0317876 A BR0317876 A BR 0317876A BR 0317876 A BR0317876 A BR 0317876A
Authority
BR
Brazil
Prior art keywords
drug release
release compositions
topical drug
stable topical
drug
Prior art date
Application number
BR0317876-5A
Other languages
English (en)
Inventor
Nicholas V Perricone
Chim Potini
Original Assignee
Nicholas V Perricone
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicholas V Perricone filed Critical Nicholas V Perricone
Publication of BR0317876A publication Critical patent/BR0317876A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"COMPOSIçõES DE LIBERAçãO DE DROGA TóPICA ESTáVEIS". A presente invenção refere-se a uma composição estável de uma droga compreendendo um portador tendo um componente de fosfatidilcolina que captura a droga que é aplicada à pele para liberação transdérmica da droga.
BR0317876-5A 2002-12-31 2003-12-31 Composições de liberação de droga tópica estáveis BR0317876A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43727902P 2002-12-31 2002-12-31
PCT/US2003/041671 WO2004060315A2 (en) 2002-12-31 2003-12-31 Stable topical drug delivery compositions

Publications (1)

Publication Number Publication Date
BR0317876A true BR0317876A (pt) 2005-12-06

Family

ID=32713159

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0317876-5A BR0317876A (pt) 2002-12-31 2003-12-31 Composições de liberação de droga tópica estáveis

Country Status (17)

Country Link
EP (1) EP1578325B1 (pt)
JP (2) JP5241995B2 (pt)
KR (1) KR100767097B1 (pt)
CN (1) CN100551345C (pt)
AT (1) ATE506969T1 (pt)
AU (1) AU2003303517C1 (pt)
BR (1) BR0317876A (pt)
CA (1) CA2511849C (pt)
DE (1) DE60336925D1 (pt)
DK (1) DK1578325T3 (pt)
ES (1) ES2362412T3 (pt)
HK (1) HK1081878A1 (pt)
IL (1) IL169169A (pt)
MX (1) MXPA05007023A (pt)
PT (1) PT1578325E (pt)
WO (1) WO2004060315A2 (pt)
ZA (1) ZA200505191B (pt)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040018237A1 (en) 2002-05-31 2004-01-29 Perricone Nicholas V. Topical drug delivery using phosphatidylcholine
AU2002950713A0 (en) 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
ES2362412T3 (es) * 2002-12-31 2011-07-05 Transdermal Biotechnology, Inc. Composiciones estables para el suministro tópico de fármacos.
ES2557475T3 (es) 2005-06-17 2016-01-26 Vital Health Sciences Pty Ltd. Un portador que comprende uno o más derivados di- y/o monofosfato de agentes de transferencia de electrones
JP2010502764A (ja) * 2006-09-11 2010-01-28 バイオマス リミテッド テルル含有化合物の局所製剤
WO2009101412A1 (en) * 2008-02-13 2009-08-20 Cipla Limited Topical pharmaceutical composition
WO2011094814A1 (en) 2010-02-05 2011-08-11 Phosphagenics Limited Carrier comprising non-neutralised tocopheryl phosphate
ES2829386T3 (es) 2010-03-30 2021-05-31 Phosphagenics Ltd Parche de administración transdérmica
EP2685992A4 (en) 2011-03-15 2014-09-10 Phosphagenics Ltd AMINO-QUINOLINES AS KINASE INHIBITORS
CN103547258B (zh) 2011-03-17 2017-10-20 特兰斯德梅尔生物工艺股份有限公司 局部一氧化氮系统及其使用方法
CA2881535A1 (en) 2012-08-10 2014-02-13 Altura Medical, Inc. Stent delivery systems and associated methods
US8871262B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Compositions and methods for treatment of osteoporosis and other indications
US8871259B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Techniques and systems for treatment of neuropathic pain and other indications
US8871257B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
US8871261B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Cancer treatments and compositions for use thereof
US8871258B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment and prevention of learning and memory disorders
US8871255B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment of skin and soft tissue infection with nitric oxide
US8871254B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system
US8871256B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and systems for treatment of inflammatory diseases with nitric oxide
US8871260B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and compositions for muscular and neuromuscular diseases
TW201440742A (zh) * 2012-12-10 2014-11-01 Uni Charm Corp 吸收性物品及安裝構件
US9750787B2 (en) 2013-03-13 2017-09-05 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9295636B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9295637B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Compositions and methods for affecting mood states
US20140271937A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9393265B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9314423B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Hair treatment systems and methods using peptides and other compositions
US9849160B2 (en) * 2013-03-13 2017-12-26 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9320758B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US20140271938A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9339457B2 (en) 2013-03-13 2016-05-17 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9295647B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9314433B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9320706B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9687520B2 (en) 2013-03-13 2017-06-27 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9314422B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9314417B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US20140271731A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US20140271742A1 (en) * 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Skin tanning using peptides and other compositions
US9241899B2 (en) * 2013-03-13 2016-01-26 Transdermal Biotechnology, Inc. Topical systems and methods for treating sexual dysfunction
US9393264B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9387159B2 (en) 2013-03-13 2016-07-12 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9724419B2 (en) 2013-03-13 2017-08-08 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
CN104840422A (zh) * 2014-02-18 2015-08-19 北京大学 一种长循环硅质体及其制备方法
US10973761B2 (en) 2015-12-09 2021-04-13 Phosphagenics Limited Pharmaceutical formulation
CN110662733A (zh) 2016-12-21 2020-01-07 埃维科生物技术有限公司 方法
US20240294603A1 (en) * 2023-03-02 2024-09-05 Transdermal Biotechnology, Inc. Systems and methods for delivery of spadin for treatment of depression or other indications
US11980651B1 (en) 2023-06-21 2024-05-14 Transdermal Biotechnology, Inc. Systems and methods for treatment of hearing using dihexa

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS607932A (ja) * 1983-06-29 1985-01-16 Dai Ichi Seiyaku Co Ltd リポソーム懸濁液およびその製法
US6165500A (en) 1990-08-24 2000-12-26 Idea Ag Preparation for the application of agents in mini-droplets
DE4208552A1 (de) * 1992-03-17 1993-09-23 Liedtke Pharmed Gmbh Topische arzneiformen mit insulin
US5976562A (en) * 1994-02-01 1999-11-02 Krall; Theodor Process for producing bactericidal/fungicidal plastic bodies
US5858398A (en) * 1994-11-03 1999-01-12 Isomed Inc. Microparticular pharmaceutical compositions
CA2181390C (en) * 1995-07-18 2001-04-24 Pankaj Modi Phospholipid formulations
US6214375B1 (en) * 1996-07-16 2001-04-10 Generex Pharmaceuticals, Inc. Phospholipid formulations
JPH10194994A (ja) * 1997-01-16 1998-07-28 Pola Chem Ind Inc 吸収促進組成物
JPH1179975A (ja) * 1997-09-05 1999-03-23 Mitsui Chem Inc マイクロカプセルの調製法
JP2000086501A (ja) * 1998-09-11 2000-03-28 Sankyo Co Ltd ヒトカルシトニンのリポソーム製剤
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
JP2003520210A (ja) * 2000-01-05 2003-07-02 イマレックス セラピューティクス， インコーポレイテッド 低い水溶性を有する薬物の送達のための薬学的処方物
US6191121B1 (en) * 2000-04-06 2001-02-20 Nicholas V. Perricone Treatment of skin damage using polyenylphosphatidylcholine
KR100508695B1 (ko) * 2001-02-13 2005-08-17 한국과학기술연구원 인슐린의 경구투여용 제형과 그의 제조방법
KR20020066778A (ko) * 2001-02-13 2002-08-21 한국과학기술연구원 체내 난흡수 물질의 흡수촉진용 조성물과 제형 및 그의제조방법
ES2362412T3 (es) * 2002-12-31 2011-07-05 Transdermal Biotechnology, Inc. Composiciones estables para el suministro tópico de fármacos.

Also Published As

Publication number Publication date
PT1578325E (pt) 2011-07-08
DK1578325T3 (da) 2011-08-08
JP2006518710A (ja) 2006-08-17
WO2004060315A2 (en) 2004-07-22
AU2003303517C1 (en) 2008-04-24
DE60336925D1 (de) 2011-06-09
IL169169A (en) 2010-12-30
JP5241995B2 (ja) 2013-07-17
KR100767097B1 (ko) 2007-10-15
HK1081878A1 (en) 2006-05-26
EP1578325A4 (en) 2006-09-13
IL169169A0 (en) 2007-07-04
CN100551345C (zh) 2009-10-21
AU2003303517A1 (en) 2004-07-29
CN1731963A (zh) 2006-02-08
KR20050094829A (ko) 2005-09-28
MXPA05007023A (es) 2005-09-12
ZA200505191B (en) 2006-04-26
EP1578325A2 (en) 2005-09-28
JP2010159278A (ja) 2010-07-22
ES2362412T3 (es) 2011-07-05
ATE506969T1 (de) 2011-05-15
CA2511849C (en) 2012-05-15
WO2004060315A3 (en) 2004-09-30
AU2003303517B2 (en) 2007-10-25
CA2511849A1 (en) 2004-07-22
EP1578325B1 (en) 2011-04-27

Similar Documents

Publication Publication Date Title
BR0317876A (pt) Composições de liberação de droga tópica estáveis
CY1113003T1 (el) Ευσταθη παρασκευασματα laquinimod
TW200714275A (en) A transdermal topical composition and its uses
TR201906416T4 (tr) Hiv inhibitörü bileşiklerin fosfonat analogları.
BRPI0513184A (pt) derivados de 2-carbamida-4-feniltiazol, preparação dos mesmos e aplicação dos mesmos em terapia
BR0312573A (pt) Derivados de fenil-[4-(3-fenil-1h-pirazol-4-il)-pirimidin-2-il]-amina
BR0207871A (pt) Composição para liberar bisfosfonato para um alvo
HN2001000244A (es) Inhibidores de espiropirimidin - 2, 4, 6 - triona metaloproteinasas.
BR0113661A (pt) Composições farmacêuticas para a liberação tópica de inibidores da enzima ciclooxigenase-2
CL2007002228A1 (es) Composicion farmaceutica topica que comprende 1-(2-metilpropil)-1h-imidazo[4,5-c]quinolin-4-amina; composiicon empacada; metodos para esterelizarlas; util para cicatrizar tejido donde la dermis se ha desgarrado.
ATE229802T1 (de) Zusammenstellung aus gemischten cyanoacrylatestern
EA200600598A1 (ru) Лекарственные формы замедленного высвобождения
GT200600194A (es) Composiciones farmaceuticas conteniendo imatinib y un componente de liberacion prolongada
HK1083009A1 (en) Topical drug delivery using phosphatidylcholine
WO2006119283A3 (en) Anti-odor compositions and therapeutic use
BRPI0518904A2 (pt) formulaÇÕes de nepafenac tàpicas
BR0315580A (pt) Derivados de metileno uréia
BR0207872A (pt) Composto para liberar agentes ativos, composição, forma de unidade de dosagem e método de administração
PA8630801A1 (es) Nuevos imidazoles
BRPI0507859A (pt) uso dos inibidores da colinesterase
BRPI0411702A (pt) uso de ácido hialurÈnico para preparar composições para o tratamento de aftas da cavidade oral
EA200601818A1 (ru) Фармацевтический препарат, содержащий дроспиренон, для нанесения на поверхность кожи
ATE412404T1 (de) Stabile orale pharmazeutische zusammensetzungen von buprenorphin und salz davon
UA87291C2 (ru) Пероральное пленкообразное лекарственное средство дезоксипеганина и способ его применения
UY29583A1 (es) Inhibidores de la adenilato ciclasa soluble

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: TRANSDERMAL BIOTECHNOLOGY, INC. (US)

Free format text: TRANSFERIDO DE: NICHOLAS V. PERRICONE

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements